Evidence map›Paper›PMID 36426350›Full record

ArticleFrontiers in immunology2022

Identification of potential candidate vaccines against

Tamara Z Ishwarlall, Victoria T Adeleke, Leah Maharaj, Moses Okpeku, Adebayo A Adeniyi, Matthew A Adeleke

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Tamara Z IshwarlallDiscipline of Genetics, School of Life Sciences, University of KwaZulu-Natal, Durban, South Africa.
Victoria T AdelekeDepartment of Chemical Engineering, Mangosuthu University of Technology, Durban, South Africa.
Leah MaharajDiscipline of Genetics, School of Life Sciences, University of KwaZulu-Natal, Durban, South Africa.
Moses OkpekuDiscipline of Genetics, School of Life Sciences, University of KwaZulu-Natal, Durban, South Africa.
Adebayo A AdeniyiDepartment of Chemistry, Faculty of Natural and Agricultural Sciences, University of the Free State, Bloemfontein, South Africa.
Matthew A AdelekeDiscipline of Genetics, School of Life Sciences, University of KwaZulu-Natal, Durban, South Africa.
University of KwaZulu-Natal · ZAFederal University Oye Ekiti · NGMangosuthu University of Technology · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Buruli ulcer is a neglected tropical disease that is characterized by non-fatal lesion development. The causative agent is

Indexed as

Bacterial VaccinesBuruli UlcerMycobacterium ulceransEpitopes, B-LymphocyteEpitopes, T-LymphocyteHLA AntigensHumansNeglected DiseasesBacterial VaccinesEpitopes, B-LymphocyteEpitopes, T-LymphocyteHLA AntigensBuruli ulcerimmunoinformaticsmulti-epitope-based vaccineMycobacterium ulceransneglected tropical disease

Identifiers

PMID36426350
PMCPMC9679648
OpenAlexW4308591638

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.